Back to search
FDAFDA · Food and drugs·Recall number Z-1301-2018

Binding Site Optilite Beta-2-Microglobulin Urine Kit, Ref LK043.L.OPT.A, IVD. The firm name on the label is The Binding Site Group Ltd., Birmingham, U.K. The Optilite Beta-2-Microglobulin (¿2M) Urine kit is intended for the quantitative in-vitro measurement of beta-2-microglobulin in urine using the Binding Site Optilite analyser to aid in the diagnosis of active rheumatoid arthritis and kidney disease. This test should be used in conjunction with other laboratory and clinical findings.

Published April 11, 2018 · Recall initiated: March 9, 2018

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
The Binding Site Group, Ltd.
Distributor
US Distribution was made to CA. There was no foreign/military/government distribution.
Lot
Lot 407460, UDI 05051700017688
Risk classification
Class II
Area (FDA)
device
Country
United Kingdom

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card